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In vitro liver preparations are increasingly used for the study of hepatotoxicity of chemicals. In
recent years their actual advantages and limitations have been better defined. The cell models,
slices, and mainly primary hepatocyte cultures, appear to be the most powerful in vitro systems,
as liver-specific functions and responsiveness to inducers are retained either for a few days or
several weeks depending on culture conditions. Maintenance of phase and phase 11 xenobiotic
metabolizing enzyme activities allows various chemical investigations to be performed, including
determination of kinetic parameters, metabolic profile, interspecies comparison, inhibition and
induction effects, and drug-drug interactions. In vitro liver cell models also have various
applications in toxicology: screening of cytotoxic and genotoxic compounds, evaluation of
chemoprotective agents, and determination of characteristic liver lesions and associated
biochemical mechanisms induced by toxic compounds. Extrapolation of the results to the in vivo
situation remains a matter of debate. Presently, the most convincing applications of liver cell
models are the studies on different aspects of metabolism and mechanisms of toxicity. For the
future, there is a need for better culture conditions and differentiated hepatocyte cell lines to
overcome the limited availability of human livertissues. In addition, strategies for in vitroanalysis of
potentially toxic chemicals must be better defined. Environ Health Perspect 106(Suppl 2):511-532
(1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/51 1-532guillouzo/abstract.html
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Introduction
Because of its interposition between the
digestive tract and the rest ofthe body, the
liver occupies a central role in major func-
tions of the organism. It receives large
amounts of nutrients and noxious com-
pounds entering the body through the
digestive tract and portal vein. Among the
major hepatic functions are uptake ofamino
acids, lipids, carbohydrates, and vitamins,
and their subsequent storage, metabolic
conversion, and release into the blood and
bile. The liver is also the principal organ
involved in the biotransformation ofexoge-
nous substances, with its capacity to convert
hydrophobic substances into water-soluble
products that can be secreted readily from
the body. However, more than a thousand
xenobiotics are potentially hepatotoxic. The
capacity ofa chemical to produce liver dam-
age in vivooften results from the interaction
ofa series ofcomplex cellular processes that
are involved in the uptake, biotransforma-
tion, and elimination of these potentially
toxic compounds. Hepatotoxins may react
with the basic cellular constituents-
proteins, lipids, RNA, and DNA-and
induce almost all types oflesions ofthe liver,
most frequently steatosis. Whatever the
agent responsible for injury, the reaction of
the liver involves a common sequence of
events that can be analyzed at the tissular,
cellular, and molecular levels. However, it is
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difficult in vivo to distinguish the primary
effects ofa compound from those induced
secondarily because liver functions are under
the influence ofvarious endogenous and
exogenous factors that result in complex
interactions with other organs. Moreover,
most ofour understanding ofliver injury
induced by chemicals remains confined to
animal models, and data obtained in ani-
mals cannot be extrapolated with certainty
to the human situation. Because of the
drawbacks of in vivo studies ofdrug- and
chemical-induced hepatotoxicity, in vitro
liver systems represent a better experimental
approach to screen potential hepatotoxic
compounds and investigate mechanism(s)
bywhich chemicals induce liver lesions. The
most frequently used isolated liver prepara-
tions include isolated perfused organ, tissue
slices, subcellular fractions, and isolated and
cultured hepatocytes. The latter model is the
most popular system and is widely used for
toxicity studies. In this review the advan-
tages and limitations of in vitro models in
toxicity studies will be discussed, with spe-
cial reference to the isolated hepatocyte
model and future developmental needs.
In Vitro Liver Models
Among the in vitro liver preparations
recognized as useful experimental models in
toxicology, intact cellular systems, i.e., the
isolated perfused organ, tissue slices, and the
isolated hepatocyte, offer various advantages
over other systems such as liver cell lines,
subcellular fractions, and genetically engi-
neered cells (Table 1). However, the isolated
hepatocyte is the mostwidelyused model.
Different in WVoLiverPreparations
The IsolatedPerfisedOrgan. The isolated
perfused liver represents the closest in vitro
model ofthe in vivo situation. The major
advantages are that the three-dimensional
architecture is preserved and that the bile
flow can be collected and analyzed sepa-
rately. It is also the only in vitro model that
allows consideration of issues related to
hemodynamics (1). This model has been
used for investigating drug- and chemical-
induced hepatotoxicity (2) and represents an
interesting tool in studies ofphysiologically
based toxicokinetic modeling. However, the
isolated perfused liver model is difficult to
handle and its functional integrity is not
maintained beyond a few hours. Although
more than one test compound was added to
the perfused medium in some studies, and
concentration-response relationships have
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Table 1.Advantages and limitations of in vitroliverpreparations.
Model
Isolated perfused liver
Liverslices
Isolated hepatocytesa
Primary hepatocyte culturesa
Livercell lines
Subcellularfractions
S9000xgfraction
Microsomes
Genetically engineered cells
Advantages
Functions close tothose ofthe in vivoorgan (all enzyme
equipment preserved)
lobular structure preserved
Functional bile canaliculi
Collection ofbile possible
Short-term kinetic studies (extraction)
lobular structure preserved (all enzyme equipment preserved)
Selective intralobular effects detectable
Studies on human liverpossible
Studies on several compounds at different concentrations
Obtained fromwhole livers orwedge biopsies
Functions closetothose of in vivohepatocytes
Studies on several compounds atdifferent concentrations
Interspecies studies
Representative ofdifferent lobular subpopulations
Cryopreservation
Functions expressed forseveral days in certain conditions
Induction/inhibition ofdrug metabolizing enzymes
Interspecies studies
Unlimited cell number
Somefunctionspreserved
Drug enzymeactivities preserved
Drug enzyme activities preserved
Production ofmetabolites forstructural analysis
One or more human enzymes expressed
Available mainlyfor CYPs
Unlimited cell number
Limitations
Short-termviability(2-3 hr)
Studyof one orafewcompounds only
Bile excretion decreased after 1 to3 hr
No studyon human liver
Suitable onlyfor liverofsmall animals
No significantreduction inthe numberofanimals used
Viability: 6 hrto 2 days
No collection of bile possible
Not all the cells preserved similarly(interassayvariability)
Short-termviability(2-4hr)
No bilecanaliculus
Early phenotypic changes
Altered bile canaliculi
Various drug enzyme activities lostordecreased
Genotype instability
Short-term studies
Short-term studies
Nocytosolic phase 11 enzyme reactions
Cofactors required foractivity
Useforspecific purposes only
No physiologic levels ofenzymes
&Other cell types, e.g., Kupffer, endothelial, stellate, and bile ductcells, can also be isolated, cultured, and even cocultured with hepatocytes.
been established in a single organ (3), this
model is not appropriate for the analysis of
various experimental conditions from a sin-
gle organ. In addition, relative to other in
vitro models, it does not significantly reduce
the number ofanimals used and human
organs are notavailable.
Liver Slices. The tissue slice model also
retains tissue organization and cell-cell and
cell-matrix interactions. However, bile flow
cannot be analyzed separately. For some
time, tissue slices have had major limita-
tions, primarily because ofpoor diffusion of
oxygen and nutrients from the incubation
medium. The development of a newly
designed tissue slicer resulted in renewed
interest for this model. Liver slices ofnearly
identical dimensions (approximately 250
pm thick) can be prepared with minimal
tissue trauma (4,5). This system appears
appropriate for short-term studies on
human liver, as tissue slices can be obtained
from both liver fragments and needle biop-
sies. Histologic examination can be con-
ducted. Recent studies have shown that
tissue slices can remain metabolically active
for 2 to 3 days (6,7). However, discrepan-
cies exist in cell viability and functional
capacity oftissue slices, probably related to
the different experimental conditions.
Moreover, some authors claim that slices
can be cryopreserved. However, to our
knowledge, viability ofparenchymal cells
afterthawinghas not been demonstrated.
Isolated Liver Cells. ISOLATION AND
CULTURE OF HEPATOCYTES. Preparation of
rathepatocytes. A considerable step forward
in obtaining intact adult rat hepatocytes
was made by the introduction ofcollagen-
ase and hyaluronidase as dissociating
agents (8). The liver is quickly perfused
with cold Ca2+-free Hanks buffer contain-
ing the two enzymes, removed, cut in
small pieces, and incubated with the enzy-
matic solution in a shaking waterbath.
Berry and Friend (9) further improved the
technique by perfusing the liver in situ
with a£Ca2+-free Hanks buffer containing
collagenase and hyaluronidase and
obtained high cell yields and viability. This
technique was modified and simplified by
Seglen (10), who developed the two-step
collagenase perfusion method now widely
used. The first step involves the perfusion
ofa calcium-free buffer. The second step is
circulation of a calcium-supplemented
buffer containing collagenase. Hepes is the
most frequently used buffer. The initial
perfusion facilitates desmosomal cleavage
and further dispersion ofliver cells. The
addition ofCa2+ to the enzyme solution
ensuresadequatecollagenase activity.
The two-step collagenase perfusion
method yields large numbers ofviable
parenchymal cells. About 40 to 60x 106
hepatocytes/g oftissue are usually obtained
from a young rat liver; cell viability ranges
between 85 and 95% as determined by the
trypan blue exclusion test; the preparation
contains less than 5% contaminating non-
parenchymal cells. Organs can be hypo-
thermically preserved for several hours
before their disaggregation without marked
loss oftheviabilityofisolated cells (11).
Hepatocyte subpopulations can also be
prepared. Perivenous or periportal hepato-
cytes can be obtained by selective destruc-
tion ofthe periportal or perivenous part of
the microcirculation bydigitonin perfusion
beforeapplyingthebasiccollagenase method
(12,13). Two whole livers must be used.
Hepatocyte subpopulations are prepared
from whole cell populations by counter-
flow centrifugation according to their
degree ofploidy (14). Enriched hepatocyte
couplet populations can also be obtained
by slight modifications of the classical
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two-step collagenase perfusion, such as
addition oftrypsin inhibitor in the collagen-
ase solution (15). The cell preparation
contains approximately 30% couplets; after
counterflow elutriation a fraction contain-
ing 85% couplets has been obtained (16).
All these methods have been applied only
to rodent hepatocytes.
The use of a crude collagenase prepara-
tion that also contains other proteolytic
enzymes reportedly alters surface properties
of parenchymal cells. To overcome this
drawback some investigators have attempted
to develop dissociation techniques without
the use of collagenase. The enzyme is
replaced by a chelating agent. Addition of
2 mM ethylenediaminetetraacetate
(EDTA) to the collagenase-free perfusion
medium allows viable hepatocytes to be
obtained (17,18); however, the yield of
hepatocytes by this method is lower and
the generation of substantial numbers of
damaged cells is unavoidable, making their
removal by the use of a percoll gradient
necessary (18). This method improves
maintenance offunctional capacities in cul-
tured hepatocytes compared to the standard
collagenase method (19), but conflicting
data have been reported (20).
Preparation ofhepatocytesfrom other
species. The two-step collagenase perfusion
protocol, first designed for rat liver, has
been applied to the liver ofvarious species,
including human (21-23). Viable hepato-
cytes have been obtained from whole livers,
lobe portions, or wedge biopsies. Isolated
hepatocytes are usuallyprepared from whole
livers when small animals are used, e.g.,
fish, frogs, birds, hamsters, and rabbits.
Wedge biopsies are frequently used to
obtain parenchymal cells from larger mam-
mals such as dogs, monkeys, ruminants,
and humans. However, even for the human
liver, the dissociation of the whole organ
has been described (24). If the basic colla-
genase protocol is used, appropriate modi-
fications must be made with respect to
cannula diameter, perfusate volumes, and
flow rates. Comparative conditions for dis-
sociation of various human samples have
been recently summarized (25).
Characteristic features of isolated
hepatocytes. Freshly isolated hepatocytes
retain responsiveness to signals to which they
reacted prior to liver dissociation. However,
some phenotypic changes have been
observed just after tissue disruption. Freshly
isolated rat hepatocytes reportedly express
c-fos (26) and exhibit changes in abun-
dances ofvarious cytochrome P450 (CYP)
transcripts (27). Moreover, conspicuous
individual variations in cellular functions are cells preserved in this medium are able to
frequently observed in human hepatocytes correctly attach to plastic and survive in
(28) (Table 2). In addition to age, sex, liver culture (36).
diseases, and genetic polymorphisms, pre- Various procedures for cryopreservation
medication and the duration and conditions of hepatocytes have been described; the
ofliver preservation before cell disruption importance of the nature and concentra-
maygreatly influence the metabolic activities tion of cryoprotectant, cooling rate, and
of freshly isolated human hepatocytes conditions of thawing have been stressed
(29,30). The conditions oforgan preserva- (37-44). Parenchymal cells from various
tion before dissociation are also critical. Vons species can be frozen (40). However, cell
et al. (31) reported that human livers stored viability is reduced and functions including
for 7±2 hr in cold University ofWisconsin drug metabolizing enzyme activities are
solution (Dupont, Paris) gave lower cellyields more or less impaired (40,44). About 50%
than surgical liver biopsies when expressed of hepatocytes that are able to attach and
per gram oftissue. Moreover, most ofthese survive in culture when plated just after
cell populations attached poorly to plastic. isolation still possess these properties after
Critical parameters are probably the length freezing in liquid nitrogen and thawing.
ofhypothermic preservation and extent of The length ofpreservation is not a critical
washingwithbufferbefore liver dissociation. parameter. Whether cryopreserved for a
Survival of isolated hepatocytes in few days or for 4 years, human hepatocytes
suspension is short, not exceeding a few were equally viable after thawing (40).
hours, and the functional capacity is depen- Among the species studied, dog hepato-
dent on the composition ofthe incubation cytes appear to be the most sensitive cells
medium (32). However, when entrapped in to the freeze/thaw process (40,44). Among
alginate beads, isolated hepatocytes survive the most sensitive functions to the
much longer. We have shown that under freeze/thaw process are cytosolic phase II
these conditions, rat hepatocytes incubated enzyme activities and protein neosynthesis,
in a culture medium were capable ofconju- which are not restored in thawed hepato-
gating bilirubin for 24 hr or more (33). cytes in pure culture. However, when
Freshly isolated hepatocytes can also be thawed parenchymal cells are set up in
transiently preserved by hypothermia or coculture with rat primitive biliary cells,
cryopreserved for months or years. When they recover levels of functional activities
stored at40Ceirher in the Leibovitz medium close to those found in fresh hepatocyte
(Gibco Laboratories, Cergy-Pontoise, cocultures after a few days (45). A recent
France) or in the University ofWisconsin study has shown that when entrapped in
solution (Dupont) (the most effective solu- alginate beads, hepatocytes exhibit only
tion for cold organ preservation), rat hepato- limited reduced cell viability and retain
cytes survived for 1 or 2 days (34-36). their functions at high levels (46).
However, survival and metabolic compe- The results with human hepatocytes
tence are better maintained in the Leibovitz deserve further comments. Indeed, although
medium. After 2 days ofstorage only the data are reproducible and similar to those
Table 2. Drug metabolizing enzyme activities in human hepatocytes.a
Enzyme activity
Substrate (reaction) Range Mean n
Ethoxyresorufinb(deethylation) 0.2-8 3.0 19
Phenacetinc(deethylation) 0.1-25 4.7 25
Pentoxyresorufinb (dealkylation) 0.1-5 0.7 19
Mephenytoinc(hydroxylation) 0.1-2 0.7 6
Dextrometorphanc(demethylation) 0.1-2 0.5 6
Nifedipinec(oxidation) 0.5-13 5.3 8
Lauric acidc(hydroxylation) 0.3-2 0.8 7
Paracetamoic
Glucuroconjugation 0.3-16 4.1 26
Sulfoconjugation 0.1-14 3.6 27
1-Chloro-2,4-dinitrobenzened(conjugation with GSH) 0.05 -0.5 0.2 14
Procainamidec(N-acetyltransferase) 0.1-7 1.1 32
Abbreviations: GSH, glutathione; n, number of tested cell populations from different donors. aActivities were mea-
sured 16 to 48 hr after hepatocyte seeding. bPicomole metabolites formed per minute per milligram cellular pro-
tein. cNanomole metabolites formed per hour per milligram cellular protein. dUnit per milligram cellular protein.
Data from Guillouzo and Chesne (28).
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obtained with animal hepatocytes when the
cells are prepared from fresh, histologically
normal liver pieces, they are much more
variable with parenchymal cells isolated
from pathologic and/or hypothermically
preserved liver samples. Further studies are
required to better define the critical condi-
tions for correct cryopreservation ofsuch
cell populations. Some biochemical parame-
ters probably should be measured and short-
term incubation or culture ofthe cells before
freezing will improve survival and function
after thawing.
Culture ofisolatedhepatocytes. To survive
for prolonged periods, liver parenchymal
cells must beput in culture. However, major
problems have been encountered with pri-
mary liver cell cultures; they are related to
limited survival (not exceeding a few days)
andtheloss ofliver-specific functions such as
drug metabolizing enzymes (47,48). CYP
concentration decreases approximately 50%
duringthefirst24 to48 hr in rodenthepato-
cytes (49-52), but the sum ofthe amounts
ofimmunoreactive protein declines more
slowly. Steward et al. (53) reported that the
total spectral CYP measured in rat hepato-
cytes dedined 68% during the first 3 days of
culture in a serum-free medium, whereas the
sum ofthe amounts ofimmunoreactive pro-
tein for seven CYP enzymes declined only
24% during the sameperiod. These findings
suggest that loss ofheme rather than protein
accounted for much ofthe observed CYP
loss in cultured rat hepatocytes. CYP
mRNAs also drop dramatically during the
first days of culture (54,55). Several
immunoblotting and Northern blotting
analyses have shown that CYP enzymes are
differently affected (55-58). Induction of
specific CYPs byphenobarbital is difficult to
achieve (59); several other CYPs, although
decreased, remain capable ofresponding to
inducers in vitro (53,56-58,60,61).
However, the response can be different from
that observed in vivo (62). Differential
changes are also observed for uridine diphos-
phatase (UDP)-glucuronyltransferase forms
(63) and glutathione S-transferase (GST)
subunits (64-67). UDP-glucuronyltrans-
ferase activity is more stable than that ofsul-
fotransferases (66). The loss ofspecific
functions is associated with an early drop of
transcription rates ofliver-specific genes, e.g.,
albumin and transferrin, that represent only
1 to 10% ofthose found in the liver after 24
hrofculture (68,69).
Phenotypic changes with time in
culture also include overexpression in adult
rat hepatocytes of P-glycoprotein, the
product of multidrug resistance gene(s),
after 2 to 3 days ofculture, making the cells
much less sensitive to anticancer drugs.
Indeed, this adenosine triphosphate (ATP)-
dependent drug efflux pump is functional,
as shown by aparallel decrease in intracellu-
lar accumulation ofdoxorubicin and the
marked effect ofknown blockers such as
verapamil and cyclosporin (70).
Most in vitro studies on determination
ofdrug metabolizing enzyme activities have
been performed on rodent hepatocytes.
However, major species differences have
been observed, particularly when compar-
isons involve human hepatocytes. Indeed,
many investigators have clearly demon-
strated that functional alterations occur later
and are more progressive in human hepato-
cytes than in their rodent counterparts
(29,71-73). About 50% ofthe initial CYP
content is still found after 1 week ofculture
(29,73), and all major CYPs (i.e., CYPiA,
CYP2C, CYP2E, and CYP3A) remain well
expressed and responsive to specific inducers
(72). Specific inductions were demonstrated
with rifampicin (72,74), 3-methylcholan-
threne (72), omeprazole (75), and dihy-
dralazine (76). As found in vivo, rifampicin
controls expression ofCYP3A at the tran-
scriptional level (77). Phase II enzymes are
also preserved in cultured human hepato-
cytes (73,78,79). However, an early
decrease has been observed for GST
activity, which was not followed by an
increase as found in rat hepatocytes (79).
Nevertheless, GSTs remain responsive to
inducers. A specific induction of GST
alpha-class transcripts by phenobarbital,
3-methylcholanthrene, and dithiolethiones
has been reported in primary human hepa-
tocyte cultures (80). P-Glycoprotein is only
slightlyoverexpressed (81).
An additional particular feature of
human hepatocytes is the frequent biphasic
expression of some mRNAs. Some tran-
scripts, particularly CYP mRNAs, show a
conspicuous drop followed by an increase
after 2 or 3 days ofculture (72,82). This
behavior could have some marked implica-
tions in metabolic capacity ofthe cells and
supports the view that human hepatocytes
can be used for various studies even after 2
or 3 days in primary culture.
Various functions are cell density
dependent. Thus albumin secretion rate per
cell is much higher when rat hepatocytes
are plated at low density (83). In conven-
tional culture conditions cell divisions, if
any, are rare, and the cells do not survive
for more than 1 to 2 weeks.
Hepatocyte subpopulations have also
been investigated in primary culture.
Tetraploid hepatocytes express higher levels
ofliver-specific functions than diploid cells,
suggesting that all genes are functional
(14). Periportal andperivenous hepatocytes
retain theirfunctional differences (84,85).
The reasons for the loss ofliver-specific
functions have been and remain a matter of
debate. The loss of a surface factor during
collagenase preparation ofisolated hepato-
cytes, as well as disruption ofthe extracel-
lular matrix and cell-cell contacts have
been proposed to be responsible for the
early and conspicuous phenotypic changes.
Recently Wright and Paine (20) evaluated
the levels of CYP in both rat hepatocyte
cultures prepared with the chelating agent
EDTA to avoid proteolysis and in liver
slices where both the extracellular matrix
and cell-cell interactions are preserved.
These authors found a loss ofCYP in both
systems, suggesting that there is no direct
relationship between such functional alter-
ations and the use ofcollagenase, the loss
ofcell-cell contacts, and/or the absence of
an extracellular matrix (20).
Obviously, different events occur during
the isolation process, cell seeding, and
attachment that can all be considered criti-
cal steps. Overexpression oftranscripts of
immediate or early genes such as c-jun and
c-fos and activation ofnudear factor kappa
B are associated with cell isolation. Rapid
degradation ofparticular mRNAs and tran-
scriptional silencing of certain genes occur
rapidlyaftercell isolation. Bothliver-specific
(e.g., some CYPs) and housekeeping (e.g.,
copper-zinc superoxide dismutase) func-
tions are involved. Otherchanges are related
to cell attachment, which results in a redis-
tribution ofmembrane receptors. A better
knowledge ofmechanisms involved in all
these events is needed to improve in vitro
survival andfunction ofhepatocytes.
Factors influencing hepatocyte survival
andfrnction. A number ofstudies dealing
with the definition ofmore suitable culture
conditions have led to the conclusion that
three groups offactors can affect cellular
functions in vitro: soluble factors, extracel-
lular matrix components, and cell-cell
interactions (86,87).
ExOGENOUS SOLUBLE FACTORS. The
composition of the culture medium has
been widely explored (88-95) (Table 3). A
variety ofsoluble factors, including hor-
mones, growth factors, and trace elements,
improve hepatocyte survival and function
in vitro (87,95,96). In addition a number
ofnonphysiologic soluble factors are also
effective; they include ligands such as
metyrapone and isonicotinamide (90),
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Table3. Soluble factors affecting survival and liver-specific functions of hepatocytes in primary cultures.
Effects
Factors Survivala Functions Reference
Corticosteroids + Some functions are improvedb Guguen-Guillouzo et al. (88)
Insulin +1- Less effective than with corticosteroids Laishes and Williams (89)
Isonicotinamide - Maintenance of CYPs improved Paine(90), lnoue et al. (91)
Metyrapone (acts as a ligand) - Maintenance of CYPs improved Paine (90)
Dimethylsulfoxide +++ Manyfunctions improved Isom et al. (92)
Nafenopin ++ Production of plasma proteins improved Bayly et al. (93)
(inhibition ofapoptosis)
Pyruvate + Somefunctions improvedb Tomita et al.(94)
Iron-containing diferric ++ Functions improvedb Block et al. (95)
transferrin
"Increased survival: -, no; +, a few days; ++ to +++, a week to several weeks. bOnly the most stable functions in
vitro, e.g., albumin production, are improved.
drug inducers such as phenobarbital (97),
and solvents such as dimethylsulfoxide
(92), which is the most effective. However,
dimethyl sulfoxide must be used at a con-
centration as high as 2% to give maximum
effects (92).
Some complex serum-free hormonally
defined media have been proposed for cul-
turing hepatocytes (98), but they do not
allow satisfactory maintenance ofspecific
gene transcription and expression ofdiffer-
entiated functions beyond a short period.
Only transitory improvement ofplasma
protein production rates (99) and drug
metabolizing enzyme levels and response to
inducers (100) has been reported in rat
hepatocyte cultures.
In standard culture conditions i.e., in
the absence ofmitogenic factors, rat hepa-
tocytes are blocked in the mid to late G1
phase at the restriction point (101). A
number ofstudies have involved the identi-
fication ofsoluble factors that may stimu-
late DNAsynthesis in hepatocytes plated at
low densities (102,103). Two groups of
humoral growth-promoting agents can be
distinguished: the primary mitogenic fac-
tors and the comitogenic factors. Thus,
epidermal growth factor requires insulin or
angiotensin II for maximal stimulation of
DNA synthesis. Serum factors such as
hepatopoietin B and the hepatocyte growth
factor also stimulate hepatocyte prolifera-
tion. In addition various substances and
culture conditions can modulate the
response ofhepatocytes to growth stimuli
in vitro. They include energetic compo-
nents of the basal medium, e.g., pyruvate
(102), lactate (102), glucose (95), proline
(104), and iron-containing diferric trans-
ferrin (104). When rat hepatocytes are
grown in serum-free medium containing
low Ca2+ concentration (0.4 mM) and
epidermal growth factor, a high percentage
go through one cycle ofdivision and a few
replicate twice (105). Nicotinamide
appears to be very effective (91,106); the
mechanism mediating these effects remains
unclear (95). About 15% ofrat hepatocytes
undergo three rounds ofcell division when
maintained in a serum-free medium con-
taining 10 mmol/liter nicotinamide and
10 ng/ml epidermal growth factor (106).
Several extracellular matrix substrates can
also promote cell growth (95,107). Loyer
et al. (101) showed that in the presence of
mitogens extracellular matrix substrates
enter S-phase 48 hr after seeding; maxi-
mum DNA synthesis takes place at 84 hr
and the maximum of mitotic figures is
observed at approximately 96 hr. Human
hepatocytes also exhibit aproliferative activ-
ity when stimulated with epidermal growth
hormone, hepatocyte growth hormone, or
human serum (108-110).
EXTRACELLULAR MATRIX COMPONENTS.
The influence ofextracellular matrix on the
maintenance ofliver-specific functions has
also been widely analyzed (111-115)
(Table 4). A variety of forms of extra-
cellular matrix were tested. The efficiency
ofattachment ofhepatocytes is increased
when the cells are cultured in plastic dishes
coated with matrix proteins. In most cases
hepatocyte spreading is also enhanced and
is associated with the loss of specific
functions (112,116,117).
Maintenance ofdifferentiated functions
is prolonged when the cells are cultured on
matrigel or in a sandwich, two conditions
that favor the preservation ofthe globular
cell shape. The most convincing improve-
ment has been obtained using matrigel, a
laminin-rich gel matrix isolated from a
mouse sarcoma (54,113). Various func-
tions, including induction of CYP2B1
and CYP2B2 by phenobarbital, are main-
tained for several days (54,55). However,
the significance ofmatrigel effects is difficult
to interpret because contamination with
proteins, hormones, and/or growth factors
has been reported (118,119). Among the
various factors identified were transforming
growth factor beta, epidermal growth factor,
insulinlike growth factor-1, bovine fibroblast
growth factor, and platelet-derived growth
factor (118).
Rat hepatocytes also maintain a high
albumin secretion rate for more than 40
days and a more cuboidal shape when cul-
tured between two layers oftype I collagen
(120). Recently Lee et al. (114) reported
that the continuous presence ofL-proline in
the medium ofsandwiched rat hepatocytes
was necessary and concluded that continued
synthesis ofendogenous collagen by hepato-
cytes was critical. However, further work is
required to determine the precise role of
L-proline and the mechanism ofinteraction
between hepatocytes and neosynthesized
collagen. Whether the cells must retain their
cuboidal shape to express differentiated
functions has been recently questioned.
Caron (121) reported that rat hepatocytes
spread on type I collagen and when exposed
to matrigel diluted in the culture medium
they showed increased transcription of the
albumin gene without induction of a
cuboidal cell shape.
Table 4. Matrix proteins affecting survival and liver-specific functions of hepatocytes in primary culture.
Effects
Protein Survivala Functions Reference
Collagens, fibronectin as substrates + Early decrease or loss Johansson and Hook(111),
Michalopoulos and Pitot(112)
Matrigel ++ Many functions well-preserved Bissell et al. (113)
for at least a few days
Collagen gel sandwich + Functions improvedb Lee et al. (114)
Dunn et al. (120)
Collagen for immobilization + Functions improvedb Koebe et al. (115)
'Increased survival: +, a few days; ++ to +++, 1 week to several weeks. bin these two systems, hepatocytes still
form a monolayer; results for a limited number of functions e.g., albumin production.
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Recently, improved maintenance and
inducibility ofCYP enzymes were obtained
in rat hepatocytes cultured on crude liver
membrane fractions (122). Saad et al.
(123) concluded that these results could be
explained by the presence ofappreciable
amounts of matrix components (e.g.,
laminin and type IV collagen) in the crude
membrane preparations (123).
CELL-CELL INTERACTIONS. Another
approach is to create cell-cell interactions in
vitro. Indeed, the liver is an organ composed
ofmany cell types, and both homotypic and
heterotypic interactions may influence liver-
specific functions (Table 5). When placed in
pure culture hepatocytes reaggregate, but
intercellular communication through gap
junctions disappears within a few hours.
Although various functions are dependent
on cell density, whether at low or high den-
sity, hepatocytes show comparable survival
times and exhibit phenotypic changes in
conventional culture conditions, indicating
that homotypic interactions are not critical
in the maintenance ofspecific functions
in vitro (83).
The first attempts to coculture
hepatocytes with other cell types such as
sinusoidal cells (124) and human fibro-
blasts (125) showed only limited improve-
ment ofhepatocyte survival and function.
A considerable step forward in long-term
maintenance ofdifferentiated hepatocytes
was made byadding another liver epithelial
cell type (126). When cocultured with rat
liver epithelial cells probably derived from
primitive biliary cells, hepatocytes from
various species including humans survive
for several weeks and retain various liver-
specific functions; these include production
ofplasma proteins, expression ofboth phase
I and phase II drug metabolizing enzymes,
and taurocholate uptake (52,71,127-135).
Cocultured hepatocytes remain able to tran-
scribe specific genes at higher values (still
representing 20 to 40% of initial values)
than those measured in cells cultured in
the presence of2% dimethyl sulfoxide or
on matrix proteins (69). The maintenance
of differentiated functions is associated
with early deposition of matrix proteins
primarily between the two cell types
(71,126,128) and with preservation of
communication through gap junctions
(136). These two features could be related
because in pure hepatocyte cultures the
addition of proteoglycans improves gap
junction activity (137). The enhanced sur-
vival and function ofhepatocytes cocul-
tured with rat liver epithelial cells have
been confirmed by many investigators
(134,138-143); the induction ofCYP2B1
and CYP2B2 by phenobarbital has also
been demonstrated (137,144). Moreover,
other cells have been effective, including
both liver endothelial cells and nonhepatic
cells (145-147). Studies from our labora-
tory (148,149) have shown that the pres-
ence of an integral plasma membrane
glycoprotein is aprerequisite to obtainlong-
term survival ofdifferentiated hepatocytes
in coculture. This glycoprotein is expressed
by both hepatocytes and rat liver epithelial
cells and is also found in some other tissues
(148,149). One could postulate that non-
hepatic cells that express this glycoprotein
are potentially capable ofinteracting with
hepatocytes. However, it is important that
these cells cease to divide when they form
confluent cell monolayers with hepatocytes
and that, like rat liver epithelial cells (69),
they can be separated from parenchymal
cells. As in conventional culture, the levels
offunctions in coculture are dependent on
the composition ofthe nutrient medium
(150). As a rule some qualitative and quan-
titative changes occur, and the reappear-
ance of fetal-like functions is not totally
prevented in coculture (65). Moreover, it
is important to point out that our cocul-
ture system is corticosteroid dependent
(151) and that not all liver epithelial cell
lines are similarly efficient to stimulate
expression ofliver-specific functions in
parenchymal cells. Therefore, it is critical
to evaluate the influence of each liver
epithelial cell line on hepatocyte function,
e.g., by measuring albumin production in
the cocultures over a 2-weekperiod.
Specific functions are also better
preserved in hepatocytes cultured in aggre-
gates. These structures are obtained by
seeding the cells into a dish so they cannot
adhere to the surface but instead reaggre-
gate with each other to form multilayer
spheroids. Such three-dimensional cul-
tures have been prepared from fetal (152),
neonatal (153,154), and adult (155) hepa-
tocytes. Dishes coated with poly(2-hydrox-
yethyl methacrylate) and positively charged
primaria dishes are used for spheroid for-
mation. Long-term secretion ofalbumin and
transferrin (155) and deposition ofmatrix
proteins (153) have been demonstrated.
Spheroids frequently contain nonparenchy-
mal cells, and it is not clear whether these
cells are essential for long-term survival of
hepatocytes. Compared to monolayer hepa-
tocyte cocultures, spheroids suffer from some
major limitations: Small aggregates tend to
fuse to form larger aggregates, cells in the
centerofaggregates do not survive, the num-
ber ofnonparenchymal cells and hepatocytes
per aggregate cannot be precisely estimated,
and the survival ofhepatocytes is usually
morelimited (152-155).
In summary, although adult hepatocytes
can express various liver-specific functions
for several weeks when placed in sophisti-
cated culture conditions, they do not fully
mimic the in vivo situation. Some pheno-
typicchanges occurearlyduringthe isolation
process and after seeding, probably as a con-
sequence ofan adaptation ofparenchymal
cells to anewenvironment. However, even if
they are lost rapidly after cell seeding, some
functions remain inducible, as shown forsul-
fotransferase activities (67). Moreover, there
is currently no experimental condition that
allows normal hepatocytes to actively
proliferate and therefore be subcultivated.
Table 5. Influence ofcell-cell interactions on survival and liver-specific functions of hepatocytes in primaryculture.
Effects
Factors Survivala Functions Reference
Homotypic factors (hepatocytes+hepatocytes) - Various functions are related either positively or negatively Guguen-Guillouzo (83)
to cell density
Heterotypic factors
Hepatocytes+Kupffer cells - No improvement Wanson et al. (124)
Hepatocytes+primitive biliarycellsb +++ A number offunctions are well maintained at high levels Guguen-Guillouzo et al. (126,128),
Begue etal. (127)
Hepatocytes+liver endothelial cellsb ++ or - Limited improvement Morin etal. (138)
Hepatocytes +3T3cellsb ++ Various functions better preserved Mendoza-Figueroa etal. (145)
&Increased survival: -, no; +, a few days; ++ to +++, 1 week to several weeks. bAll the cells interacting with hepatocytes express a liver-specific regulating protein on their
plasma membrane (148).
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ISOLATION AND CULTURE OF HEPATIC
NONPARENCHYMAL CELLS. Kupffer and
endothelial cells can be obtained by the col-
lagenase-pronase method and further sepa-
rated by elutriation (156). Maintenance
and propagation ofliver endothelial cells in
culture have been difficult, though to some
extent successful (157).
Stellate cells are purified from
nonparenchymal cells first isolated by the
pronase-collagenase method, using a
single-step density gradient centrifugation
with Nicodenz (Nyegaard and Co., Oslo,
Norway) at a final concentration of 11.4%
(158). Freshly isolated stellate cells display
a morphologic appearance similar to that
observed in situ. During the first 3 days
after seeding, stellate cells appear homo-
genous and show characteristic morphol-
ogy with lipid droplets surrounding the
nucleus. During the following days they
divide and transform into myofibroblasdike
cells expressing desmin and iso-a-actin and
producing increased amounts ofcollagen.
Both intrahepatic biliary and gallbladder
epithelial cells can be isolated and cultured.
Intrahepatic biliary cells have been obtained
by immunoisolation with an antibody that
recognizes a cell-surface glycoprotein local-
ized only on these cells in the liver; they can
be maintained for a short period using stan-
dard culture conditions (159). Gallbladder
epithelial cells are obtained from gallbladder
mucosa bycollagenase treatment (160,161);
they attach to various substrates and rapidly
proliferate. Gallbladder biliary cells express
specific markers such asy-glutamyltranspep-
tidase and cytokeratins and maintain mucus
secretion foratleast 1 weekin culture (162).
Liver CellLines. Characteristics ofliver
cell lines include unlimited subcultivation
and cell availability in large numbers.
Hepatocyte cell lines can be obtained from
hepatomas or after transfection ofnormal
hepatocytes with viral or cellular DNA.
Various hepatoma cell lines have been estab-
lished from rodent or human hepatomas;
however, none of them express the full
spectrum ofdrug metabolizing enzymes.
Moreover, marked deviation ofthe pheno-
type and genotype usually occurs with
time in culture. Similarly, none of the
immortalized rodent and human hepatic
cell lines established to the present have
retained all tissue-specific functions and can
be considered to reflect the in vivosituation.
Nonparenchymal cell lines have also
been obtained. Thus, rat liver epithelial
cells, probably derived from primitive biliary
cells and isolated by trypsinisation of the
liver ofyoung rats, transform in vitro and
can be cultured indefinitely. They express
only a few hepatic functions; e.g., CYP2E1
and epoxide hydrolase activity (163).
Subcellular Fractions. Subcellular
fractions, i.e., tissue homogenates, micro-
somes, and purified organelles such as mito-
chondria and nuclei, are also useful in
studying mechanisms ofdrug- and chemi-
cal-induced hepatotoxicity. The liver
9000xg supernatant fraction and micro-
somes fortified with cofactors have long
been recognized as a good metabolizing sys-
tem for activation ofxenobiotics in in vitro
mutagenicity testing procedures (164).
Microsomes are also used to detect lipid
peroxidation induced by hepatotoxins.
Isolated mitochondria are used to study the
effects ofchemicals on oxidative phospho-
rylation, ATP synthesis, and [-oxidation of
fatty acids. Isolated nuclei are used in run-
on experiments for gene transcription
analyses. Like perfused liver and suspended
isolated hepatocytes, subcellular fractions
are functional onlyfor a shortperiod.
Genetically Engineered Cells. Yeasts,
bacteria, insect cells, and nonhepatic mam-
malian cells have been transfected with
cDNA-encoding human CYPs and express
transiently or stably one or several human
CYPs. They are useful to identify CYPs
involved in the metabolism ofchemicals,
covalent binding, and drug inhibition
studies (165). More recently, cells trans-
fected with the cDNA for various phase II
enzymes have also been obtained (166,167).
An unlimited number oftransfected cells
can beprepared in an inexpensive way.
In Vitro Liver Models
in Toxicity Testing
The evaluation ofthe safety ofa chemical
before human exposure represents a critical
step. Chronic toxicity studies during the
development ofa new drug are time con-
suming and costly. They are usually per-
formed on two animal species: a rodent
and a nonrodent such as dog or monkey.
Because marked interspecies differences
frequently exist in both the rates and the
routes of drug metabolism, particularly
between humans and animals, toxicologic
data obtained in two animal species cannot
be extrapolated to the human situation
without risk.
For these reasons as well as for ethical
considerations, there is considerable inter-
est in reducing animal usage and toxicity
testing costs. Moreover, it is desirable to
clearly establish human risk before human
exposure to chemicals. This explains why
in vitro approaches have received increased
attention in recent years. Because the liver
is the primary target organ, in vitro liver
systems, especially the isolated hepatocyte
model, have been widely used for toxicity
testing. They have the potential to provide
information about howchemicals are metab-
olized and how the liver can be adversely
affected by a toxic agent. This implies that
in vitro liver preparations are metabolically
competent and produce the same metabo-
lites as in vivo. Isolated hepatocytes, either
in suspension or in primary culture, are
used for screening evaluation ofdifferent
classes of chemicals; cytotoxicity can be
assessed by nonspecific and/or liver-specific
end points. However, the most frequent use
ofthese models is for mechanistic studies of
the action ofhepatotoxins.
CytotoxidtyMeasures
Awide array ofmorphologic and biochem-
ical markers are available for obtaining
information at the cellular and molecular
levels to detect and measure chemical-
induced perturbations (168). Several classi-
fications can be proposed: e.g., parameters
that estimate plasma membrane integrity
and parameters that estimate subcellular
effects; parameters that assess irreversible
cytotoxicity (cell death) and reflect reversible
changes; or nonspecific and liver-specific
end points.
Nonspecific EndPoints. Nonspecific
end points are usually used to estimate irre-
versible cellular damage. The choice of
cytotoxicity indicator depends on a number
offactors that indude correspondence with
the lesion being induced in vivo, reliability,
reproducibility and sensitivity, convenience,
cost, and species specificity. Nonspecific
criteria may monitor morphologic changes,
membrane integrity, subcellular perturba-
tions, and metabolic activities. Light micro-
scopic examination is useful to support
biochemical end points; cell rounding, cell
detachment, blebbing indicative of cell
membrane and cytoskeleton disturbance,
vacuolization, and accumulation oflipid
droplets can be visualized, whereas trans-
mission electron microscopy is required to
detect subtle alterations oforganelles.
End points for in vitro cytotoxicity
evaluation include the following:
Morphologic parameters
* Light microscopy: cell shape, nuclear and
cytoplasmic alterations; accumulation of
vacuoles; lipid droplets, formation of
blebs; cell attachment and detachment
(cell count)
* Electron microscopy: alterations of
organelles
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Biochemical parameters
* Plasma membrane integrity: protein or
DNA content; trypan blue exclusion
test; enzyme leakage (lactate dehydroge-
nase [LDH], transaminases); release of
51Cr; neutral red uptake
* Alterations ofcell permeability: leakage
ofions and small molecules (K+ con-
centration; Ca2+ flux); accumulation of
exogenous molecules (succinate, etc.)
* Metabolic parameters: 3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyl-tetrazolium
bromide (MTT) test (reduction of a
formazan salt); ATP content; protein
neosynthesis; lactate/pyruvate ratio;
glutathione (GSH) content; lipid
peroxidation; covalent binding
PLASMA MEMBRANE DISTURBANCES. Loss
ofplasma membrane integrity. Assays for loss
ofmembrane integrity are indicators ofirre-
versible cell injury; they include cell count
(percentage ofattached cells), trypan blue
exclusion, andcytosolic enzyme leakage.
Cell death (necrosis) is the consequence
of loss of plasma membrane integrity
assessed by trypan blue uptake and leakage
ofcytosolic enzymes. The trypan blue exclu-
sion test is widely used to estimate the per-
centage ofviable cells in isolated hepatocyte
suspensions. Several enzymes are used for
monitoring cell viability. The extracellular
LDH to total LDH ratio correlates better
than that ofother enzymes with morpho-
logic changes observed by phase-contrast
microscopy and cell viability assessed by try-
pan blue exclusion (169,170). This greater
sensitivity ofLDH can be explained by the
intracellular compartmentalization of
transaminases; thus 80 to 85% ofaspartate
aminotransferase is found in mitochondria.
However, LDH is not a constant reliable
indicator of loss of plasma membrane
integrity and cell death; it is a less reliable
and less sensitive parameter for human
hepatocytes than for their rodent counter-
parts (171,172). Reliable values are
obtained by the determination ofintracellu-
lar LDH (172), an index also used to count
viable hepatocytes (117,173). However, in
some cases, it could be advisable to also
determine ifviable cells have detached.
The release of5'Cr is another end point
of cell death; it measures membrane
integrity. This index has some limitations
because the cells must be preloaded with
the isotope and 51Cr is not entirely released
bylysed cells.
Most of the tests used to estimate
irreversible cellular damage can be con-
ducted in 96-well plates with 30,000
cells/well. Anumber oftests used to evaluate
cell density in the cultures are now
miniaturized and automated (174).
Dose-response curves are calculated from
the results obtained, then the results are
summarized as median inhibition concen-
tration (IC50) values; i.e., the concentra-
tions of test chemicals that modify the
response oftest wells by 50% (175). ICIO
values are sometimes used, as they are con-
sidered the lowest concentrations causing
statistically signiflcant cytotoxic effects
(176). However, the IC50 value is usually
considered the best indicator of in vitro
cytotoxicity because it is taken from the
middle ofthe dose-response curve (176).
Another index, i.e., the maximum non-
toxic concentration over a given incuba-
tion period, can also be calculated and is
useful for designing long-term toxicity
studies with repeated additions of the
chemical (177). The most widely used
tests quantitate some cellular components
such as DNA and proteins or estimate the
number ofviable cells (e.g., by the reduc-
tion ofMTT by mitochondrial succinate
dehydrogenases or the uptake ofneutral red
in lysosomes, the latter being frequently
more sensitive).
Reversibleplasma membrane alterations.
Other indices of toxicity may reflect
reversible injury. Thus increased perme-
ability ofplasma membranes to ions and
small molecules precedes total loss ofcell
viability. Aloss ofintracellular K+ and alter-
ation ofCa2+ ion flux are usually observed.
Changes in 02 consumption estimated
after addition ofexogenous succinate also
precede irreversible injury.
SUBCELLULAR CHANGES. With the
exception ofdirect action ofa toxic com-
pound on the cellular membrane, subcellu-
lar changes also occur prior to loss of
plasma membrane integrity. Subcellular
changes can be visualized by functional
changes and electron microscopic examina-
tion. The functional indicators are based on
evaluation ofenergy conservation, e.g.,
ATP content and metabolic competence,
e.g., lactate/pyruvate ratio, and protein syn-
thesis. Both secreted and intracellular
neosynthesized proteins can be estimated.
Metabolic disturbances must be significant
and reproducible to be taken into consider-
ation. They often far precede irreversible
cellular injury. Whether the effects are
reversible is also an important question that
is rarelyanswered (178).
OTHER INDICATORS OF REVERSIBLE
CELLULAR DISTURBANCES. Other indica-
tors ofreversible cellular disturbances exist
that indicate a potential for injury without
insight into particular site(s). The most
frequently used indicators that fit into this
category are GSH content, lipid peroxida-
tion, and covalent binding of reactive
compounds to cellular macromolecules.
Glutathione levels. The tripeptide GSH
is the most efficient protection ofthe cells
against reactive metabolites and free radi-
cals. GSH is an essential cofactor for GSH
peroxidase and removes hydroperoxides; it
is converted to its oxidized form (GSSG).
GSH is also involved in the conjugation
and inactivation by GST, of reactive
metabolites formed by oxidation reactions.
Intracellular GSH levels are usually mea-
sured by a fluorimetric method. GSSG is
toxic to the intracellular medium. It is con-
verted back to GSH by the GSH reductase
pathway. The most common pathway of
GSH depletion in drug toxicity is excessive
consumption of GST without recovery.
One ofthe consequences ofGSH depletion
can be the modification ofthe sulfhydryl
groups to arylating and oxidizing species
(179). Several xenobiotics induce an oxida-
tive stress that results in S-thiolation of
proteins, presumably by thiol-disulfate
exchange (180). Two mechanisms ofdethi-
olation ofproteins have been identified,
both ultimately requiring GSH and enzy-
matic reduction by reduced nicotinamide
adenine dinucleotide phosphate: one
involves GSH and GSH reductase and the
other involves thioredoxin and thioredoxin
reductase, a thiol reductant showing abroad
specificity for reduction ofdisulfides (180).
GSH is also present in mitochondria; it
prevents the effects ofoxidants generated
during oxidative phosphorylation on sensi-
tive thiol groups (181). Mitochondria rely
on GSH peroxidase, and hence on GSH,
to detoxifyhydroperoxides.
Both GSH and GSSG can be measured
enzymatically or detected by high-perfor-
mance liquid chromatography, but both
methods lack sensitivity. Consequently,
intracellular GSH levels areusuallymeasured
by afluorimetric method (182).
Lipidperoxidation. Lipid peroxidation
results from interaction of unsaturated
lipid components with oxygen free radicals
or excess H202 generated by toxic com-
pounds during metabolism. Various ana-
lytical methods are used to measure lipid
peroxidation products in vitro; they are
based on the detection ofintermediates,
reactants, and end products oflipid peroxi-
dation. The methods include measurement
ofmalondialdehyde formation using the
thiobarbituric acid reaction, spectrophoto-
metric detection of lipid-conjugated
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dienes, measurement of evolved gaseous
hydrocarbons (ethane and pentane), quan-
tification of fluorescent pigments, and
chemiluminescence (183). Two widely
used markers of lipid peroxidation are
extracellular free malondialdehyde forma-
tion (although it appears to be related to
only 10% ofthe total lipids oxidized esti-
mated on the ultrafiltrate of culture
medium by size-exclusion chromatogra-
phy) and conjugated dienes evaluated by
the second-derivative ultraviolet spec-
troscopy ofthe cell lipid extract (184). A
promising method is the detection offree
radicals by spin trapping in whole cells by
electron paramagnetic resonance (185).
Covalent binding. Covalent binding of
reactive compounds to cellular macro-
molecules has been considered to be an
important mechanism ofhepatotoxicity by
xenobiotics (186). However, cellular
targets (mainly proteins) and their intra-
cellular location remain obscure and the
significance ofcovalent binding ofreactive
chemicals to proteins in the appearance of
cell death is not obvious. Moreover, it has
been reported that in hepatocytes treated
with acetaminophen, covalent binding asso-
ciated with denatured cell material is about
twice the level ofbinding measured in viable
cells (187), making the use ofappropriate
controls essential and making overestimation
ofcovalent binding likelywhen a fraction of
treated cells is irreversiblydamaged.
Liver-Specific Criteria. A number of
markers representative ofthe various liver-
specific functions can also serve as parame-
ters offunctional disturbances in isolated
hepatocytes exposed to xenobiotics. The
most widely tested markers include neosyn-
thesis ofliver-specific plasma proteins such
as albumin and transferrin and acute-phase
proteins, glyconeogenesis, and glycogen syn-
thesis (188); urea synthesis (189); lipopro-
tein synthesis; induction or inhibition of
specific CYPs (190); and bileacid secretion.
Various specific alterations oforganelles
can also be observed in liver parenchymal
cells by electron microscopic examination,
e.g., proliferation ofsmooth endoplasmic
reticulum, increased number of peroxi-
somes associated with induction ofthe per-
oxisomal P-oxidation pathway (191), and
characteristic accumulation of concentric
membranes in lysosomes.
These criteria are usually much more
sensitive than end points of the plasma
membrane integrity; theycompare to criteria
for metabolic competence. However, with a
few compounds major differences can be
observed. Thus, cycloheximide inhibits
protein synthesis but not urea synthesis,
whereas norvaline does the opposite (192).
ChoiceofExperimental Conditions
Experimental conditions must be carefully
defined; they can greatly affect the results.
Among the major parameters to be consid-
ered are the functional capacity of the
cells, composition of the medium, the
physiochemical properties ofthe test com-
pound, duration of treatment, and choice
ofend points.
Retention ofXenobiotic Metabolic
Capacity by IsolatedHepatocytes. A num-
ber ofcompounds are hepatotoxic only after
biotransformation. The production ofreac-
tive metabolites is dependent on a balance
of activation and inactivation pathways;
therefore, it is critical to demonstrate that
isolated hepatocytes are capable ofproduc-
ing the same metabolites as those formed in
vivo. The parent xenobiotic and metabolites
can be measured in both media and cell
extracts and their intracellular covalently
bound percentage can be estimated.
A number ofstudies have shown that
hepatocytes retain their ability to gener-
ate metabolites identical to those found
in vivo. Consequently, this model is suit-
able for demonstrating interspecies vari-
ability and potential drug interactions
(127,193-202). The results with human
cells were either close to or quite different
from those obtained with hepatocytes from
the most frequently used animal species.
A good in vivo/in vitro qualitative
correlation for metabolites formed by both
phase I and phase II pathways is usually
found. However, various parameters such
as chemical concentration and the duration
ofthe incubation with the chemical may
greatly affect the metabolic profile. Some
drugs are rapidly and actively metabolized
whereas others are transformed much more
slowly. Conjugated metabolites can be
detected only after 6 to 8 hr ofincubation
or more (127). In a recent study we found
that minor metabolites were detected only
after two or three daily exposures to the
compounds (203). The choice ofdrug con-
centrations to be tested is also important.
Some metabolites can be missed ifthe con-
centration is too low; ifthe concentration is
too high cellular toxicity can result. It is
appropriate to test at least two concentra-
tions, with the highest close to the maxi-
mum nontoxic concentration. However, for
some drugs, in vitro biotransformation is
low and does not reflect the in vivosituation
whatever culture conditions are used (204).
Such striking quantitative differences are
sometimes minimized when metabolites
are expressed per cell, as shown by Berthou
et al. (204) for caffeine. In addition, the
metabolic profile obtained with hepato-
cytes can be quite different from a meta-
bolic profile obtained from a given
compartment in vivo (e.g., urine or plasma)
and it misses metabolism in nonhepatic tis-
sues in vivo. In vivo/in vitroquantitative dif-
ferences can be much more pronounced in
one species compared to another. The new
drug S-3341 was poorly metabolized both
in humans and in primary human hepato-
cyte cultures (4 and 20%, respectively), but
was much more biotransformed in vitro
than in vivo in the rat (63 vs 20%) (205).
There is evidence for stereoselective and
competitive metabolism ofdrugs, and the
implications on the induction ofliver cell
damage should be considered. Le Corre et al.
(206) have analyzed stereoselective metabo-
lism ofdisopyramide in human hepatocyte
cultures. The metabolic rate ofS(+) disopy-
ramide was 2.5-fold higher than that ofR(-)
disopyramide. The stereoselective index
S(+)/R(-) was similar to that found in vivo
(1.51 ±0.11 vs 1.55±0.10). Hepatocyte cul-
tures also represent a powerful system to
demonstrate or predict drug interactions
(200,207). Exposure ofhuman hepatocytes
to various concentrations oferythromycin
estolate results in a dose-dependent inhibi-
tion ofcyclosporine metabolism; both com-
pounds are transformed by CYP3A4.
Erythromycin estolate that is hepatotoxic in
vivo forms stable complexes with CYP3A
both in vivoand in vitro (208,209).
The capacity of hepatocytes to form
metabolites decreases with time in culture;
as expected from measurement of drug
metabolizing enzymes, it drops much ear-
lier in rodent hepatocytes than in their
human counterparts (198). For example,
no change in the metabolic rate and percent-
age of the two major metabolites formed
from ketotifen was observed in human
hepatocytes during the first 4 days ofcul-
ture; the metabolic rate markedly decreased
in rat hepatocyte cultures between day 2
and day 4.
The use of more sophisticated culture
conditions is required for prolonged main-
tenance of drug metabolism activity in
cultured hepatocytes; this is of particular
importance when the cells must be induced
in vitro before addition ofthe test drug. By
using the coculture system, i.e., hepato-
cytes mixed with rat liver epithelial cells,
Villa et al. (210) demonstrated that ery-
thromycin estolate induced CYP and
formed inactive complex with the iron of
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the induced CYP in rat hepatocytes. In
cocultured human hepatocytes, caffeine
and theophylline metabolism were increased
5.8 ±2.3- and 3.3± 1.1-fold, respectively,
after a 3-day treatment with 3'-methyl-
cholanthrene (211). Glucuronidation of
ketotifen was still demonstrated after 3
weeks ofcoculture, whereas no conjugate
was detected in 6 days pure culture (127).
Huge interindividual variations are fre-
quently observed in drug metabolic profiles
in human hepatocyte cultures, making it
critical to test at least two different cell
populations and evaluate functional capac-
ity ofeach cell population by measuring
various phase I and phase II enzyme activi-
ties. Such a metabolic analysis may deter-
mine whether the cells that are being used
in vitro are from an individual with partic-
ular metabolic characteristics related to fac-
tors such as genetic polymorphism, for
instance, or to environmental factors (e.g.,
heavysmokers, drugabusers, etc.).
Composition ofthe Medium. The
composition of the culture medium may
greatly affect the response ofisolated hepa-
tocytes to cytotoxic agents. Cytotoxicity of
sodium salicylate to cultured rat hepato-
cytes is dependent on the concentration of
bovine serum albumin in the medium
(212). Various compounds bind proteins.
Villa et al. (190) found that the toxicity of
erythromycin estolate (known to bind pro-
teins) in rat hepatocytes increased in a
medium deprived ofproteins. The addi-
tion ofcalcium to the medium has been a
matter ofdebate. Indeed, extracellular Ca2+
has paradoxical beneficial and detrimental
effects to isolated hepatocytes exposed to
toxic compounds. Calcium chloride in the
incubation medium (3.6 mM) enhanced
carbon tetrachloride (CC14) toxicity in rat
hepatocytes (213-216) and it was hypoth-
esized that calcium entry into the cell may
be involved in liver cell damage. In con-
trast, Smith et al. (216) report that several
cytotoxic agents caused less injury to cul-
tured hepatocytes in the presence of 2.6
mM calcium than under calcium-free con-
ditions. Edmonson and Bang (217) demon-
strated that in the absence ofextracellular
calcium, isolated hepatocytes rapidly release
LDH and fail to accumulate y-aminoisobu-
tyric acid. Stacey and Klaassen (218)
reported that isolated hepatocytes exposed
to cadmium and copper amphoterin show
no change inviabilitywith the addition of1
mM calcium chloride; however, omission of
Ca2+ reversed cytotoxicity ofthe calcium
ionophore A23187. Recent evidence shows
that in many chemical toxicities an increase
in intracellular free calcium can be
dissociated from the toxicity generated by
that agent (219,220), supporting the idea
that the rise in intracellular calcium is a
consequence ofcell membrane injury. By
using imaging fluorescence microscopy, the
temporal relationships between changes in
Ca2+ and cell death were evaluated in indi-
vidual cells. Sakaida et al. (219) showed
that oxidative stress produced by tert-butyl
hydroxyperoxide induced three distinct
phases of increased cytosolic-free calcium
concentration that occurred somewhat asyn-
chronously in primary rat hepatocyte cul-
tures. Harman et al. (220) reported that in
acetaminophen-treated mouse hepatocytes,
intracellular calcium concentration increased
well after the appearance ofcell surface blebs
andshortlybefore cell death.
Drug Incubation Conditions. When
evaluating the toxicity ofa test chemical to
isolated hepatocytes, the investigator must
be aware that a number ofproblems regard-
ing chemical incubation conditions affect
the quality and accuracy of the results.
Before starting the experiment on hepato-
cytes a number of questions must be
addressed: What solvent can be used to dis-
solve the compound? Is the compound
volatile?Are reactions occurring between the
compound and the medium that will affect
pH, osmolarity, or turbidity? Will reactions
result in the formation ofprecipitates?
Duration ofTreatment. The duration
ofincubation with chemicals can be a critical
parameter because ofthe lack ofextrahepatic
elimination oftoxic compounds and the
accumulation ofcompounds in the culture
medium. Paine and Hockin (221) studied
the effects ofthree groups oftoxins on cul-
tured rat hepatocytes maintained in condi-
tions that resulted in either a low or a high
concentration ofCYP. As predicted, toxins
that are not metabolized by CYP, i.e., ethio-
nine and galactosamine, were equally toxic
regardless ofthe CYP concentration. In con-
trast, the two other groups oftoxins had
nonpredictable behavior. Indeed, com-
pounds that are activated by CYP (CC14,
bromobenzene, cyclophosphamide, paraceta-
mol) and those that are detoxified by CYP
(pentobarbital, strychnine) were also equally
toxic regardless ofthe CYP content ofthe
cells after a24-hrincubation. Onlywhen the
exposure was limited to 1 to 4 hr and fol-
lowed by a 20-hr incubation in a toxin-free
medium was CC14 more toxic to cultured
hepatocytes containinghighlevels ofCYP.
Short-term assays, however, do not
reflect the common in vivo situation in
which drugs often produce liver damage
after repeated administration for weeks or
months. For long-term toxicity, in vitro
models in which hepatocytes retain their
metabolic activities are required. Cocultures
ofhepatocytes with rat liver epithelial cells
offer an attractive approach for estimating
chronic toxicity ofchemicals (177,205).
Various drug concentrations can be tested
beginning when cell confluency is reached
and with daily renewal. The highest concen-
tration used is the maximum nontoxic con-
centration, defined after a 24-hr incubation
ofthe compound with pure hepatocyte cul-
tures. Depending on the chemical tested,
four situations can be observed: no cytotoxi-
city to both cell types is found; onlyhepato-
cytes are damaged; only rat liver epithelial
cells are damaged; and both cell types are
sensitive to the chemical. As in acute toxicity
testing, major differences in the sensitivity of
end points can be observed (177). Because
rat liver epithelial cells used in coculture do
not metabolize drugs, comparisons ofthe
effects ofsimilar drug concentrations on
pure cultures ofthese cells make it possible
to determine whether a drug requires bio-
transformation to be cytotoxic. The cocul-
ture model thus has a double interest: it
allows the detection ofa cumulative chemi-
cal-induced toxic effect as well as the ability
to distinguish between compounds that
require biotransformation to induce cellular
injury. Thus amitryptiline, but not cloni-
dine, exerted a cumulative toxic effect in rat
hepatocyte cocultures (177).
Choice ofEnd Points. A single end
point is usually sufficient to estimate
irreversible injury induced by toxic com-
pounds. For example, comparable results
were obtained with primary rat hepatocyte
cultures exposed to various compounds by
measuring extracellular and total LDH
ratio, total cellular protein content, MTT
assay, and neutral red uptake (174). When
metabolic competence is evaluated, IC50
values can be much lower than those calcu-
lated from parameters ofplasma membrane
integrity and false negative compounds
have been reported. The advantage ofcrite-
ria reflecting both irreversible cellular dam-
age and altered metabolic competence is
that they allow determination ofmetabolic
disturbances with concentrations of the
toxic agent much lower than those required
for cell death.
DetectionofCytotoxic
andGnotoxicCompounds
Comparative Screening ofCytotoxic
Compounds. Isolated hepatocytes, either
in suspension or in culture, represent a
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unique experimental approach to screening
various compounds at several concentra-
tions using different criteria on the same
cell suspension. However, they are not
suitable for screening idiosyncratic toxins
having a hypersensitivity origin because
these involve an immune reaction.
Only short-term studies not exceeding
2 to 4 hr can be performed with suspen-
sions offreshly isolated parenchymal cells.
Moreover, it must be considered that the
cells are altered, primarily because ofthe
use ofcollagenase and mechanical agita-
tion. Among the altered functions are lower
5'-nucleotidase and alkaline phosphatase
activities and response to hormones.
Consequently, it is probably more effective
to allow hepatocytes to recover from the
trauma ofisolation and regain metabolic
properties. However, one has to face major
changes affecting various phase I and phase
II enzymes after a few hours of culture.
This explains why most studies on attached
parenchymal cells have been conducted
over a short period oftime not exceeding
24 hr andwith the addition ofa single dose
of the test chemical. Comparison of the
data obtained with nonhepatic cells such as
HeLa cells indicates that hepatocytes are
usually more sensitive to compounds that
require metabolic activation (222). Normal
hepatocytes also are often more sensitive
than hepatoma cells, which exhibit lower
drug metabolizing enzyme activities (174).
Species differences in the sensitivity ofthe
cells are also frequently observed.
The suitability ofisolated hepatocytes as
a screening procedure early in drug devel-
opment is more convincing when struc-
turally related compounds are tested, as we
have shown for neuroleptic agents (170)
and macrolide antibiotics (190). Chemicals
associated with hepatotoxicity in humans
are usually more cytotoxic to rat or human
hepatocytes in vitrothan nonhepatic-related
toxic compounds, particularly those that
require hepatic biotransformation to exert
cellulardamage.
It is obvious that the utility of in vitro
systems depends on confidence in extrapo-
lating data to the in vivo situation. For
such comparisons the most useful parame-
ters are those that assess end point toxicity
for which in vivo data (histology, elevated
serum enzyme levels, median lethal dose
[LD50]) are most readily available.
Several in vitro toxicity studies on
cultured hepatocytes have been designed to
establish comparisons with in vivo hepato-
toxic responses. In general, the in vitro/in
vivo correspondence in discriminating
between hepatotoxicants and nonhepato-
toxicants is good. Story et al. (169) tested
34 chemicals for cytotoxicity in cultured
rat hepatocytes by measuring transaminase
release after 2 and 5 hr ofexposure. Agood
correlation between in vitro cytotoxicity
and in vivo hepatotoxic response was
found. Tyson et al. (223) investigated 23
chemicals and found good correspondence
for all but two (thioacetamide and allyl
alcohol) on the basis of enzyme release.
Inconsistencies can be related to the nature
ofthe chemical tested, the incubation con-
dition, and the end point tested. Indeed, a
simple protocol for in vitro cytotoxicity
testing cannot be used for all kinds ofcom-
pounds. Fautrel et al. (174) tested 30
coded liquid or coded solid compounds on
primary rat hepatocyte cultures using
96-well plates and did not find a good in
vitro/in vivo correlation for all compounds
tested. Obviously in agreement with other
works, their study indicates that volatile
and liposoluble compounds require appro-
priate culture conditions. Tyson et al. (224)
found that relative hepatotoxic potentials
for five haloalkanes measured in hepatocyte
suspensions and in vivo were ranked cor-
rectly ifpartition coefficients were factored
into the data to reconcile the differences
between solvent volatility and retention in
the two systems. Obviously more informa-
tion is needed on compounds for which no
correlation is found between in vivoand in
vitro data. This will be of great help in
designing more suitable in vitro tests and
for ourknowledge about their limitations.
IC50 values have been compared with
in vivo lethal doses. In a multicenter study
we compared neutral red uptake IC50 val-
ues obtained with primary rat hepatocyte
cultures and oral, ip, or iv LD50 values.
A significant correlation was found only
between IC50 and iv LD50 values (225).
Similarly, Jover et al. (176) found a good
correlation between MTT IC50 on cultured
human hepatocytes and human acute lethal
blood concentration for 10 chemicals.
Another important question is the corre-
lation between in vitro toxic concentrations
and the in vivo toxic doses. Such a correla-
tion must take into account the pharma-
cokinetics ofthe drug; it remains an open
question that requires further investigation.
Screening ofGenotoxic Compounds.
In vitroliver models have long been used to
assess the genotoxic potential ofchemical
and physical agents on the basis of their
ability to covalently bind to and damage
DNA, induce DNArepair responses, mutate
specific genetic loci, induce phenotypically
altered cells, or induce chromosome or
chromatid-level aberrations (226-228).
Metabolism of chemicals is frequently a
necessaryprerequisite.
Because they retain the critical activa-
tion/inactivation balance, isolated hepato-
cytes are well suited for quantitation of
DNA repair elicited by exposure to geno-
toxic agents ofa wide variety ofstructural
classes. Only a few chemicals, including
cimetidine (229), P-naphthylamine, 2,6-
diaminotoluene, and 5-methylchrysene
(230), give a qualitatively different response
between the human and rat hepatocytes. In
the last study, 25 compounds were tested;
compounds found to be genotoxic in vivo
were negative in vitro in only one case out
ofeight. Extensive validation has been per-
formed with rat hepatocytes (231) and the
hepatocyte primary culture/DNA repair
test is now widely accepted by testing and
regulatory agencies. Because the unsched-
uled DNA synthesis (UDS) assay requires
small numbers of cells, it represents the
suitable method to test genotoxic com-
pounds on human hepatocytes (230).
Various chemicals induce UDS in human
hepatocytes; they include nitrosamines, 2-
acetylaminofluorene, benzo[a]pyrene, afla-
toxins, and dinitropyrenes. Aflatoxin B1,
a suspected human hepatocarcinogen,
induces a UDS response at or below 1 pM.
Surprisingly, although the UDS response
is usually similar in human and rat hepato-
cytes (232), marked differences are found
when human hepatocytes are compared to
hepatocytes ofother animal species (233).
Because clonal growth ofhepatocytes
remains unsuccessful, direct mutagenesis
assays with hepatocytes are not possible.
To obviate this difficulty, hepatocytes can
be cocultured with actively proliferating
cells such as human fibroblasts (234) or
V-79 Chinese hamster fibroblasts (235).
Moreover, the low growth capacity ofpri-
mary hepatocytes makes their wide use for
assays such as the micronucleus and sister
chromatid exchange questionable.
The UDS test with isolated hepatocytes
is becoming more significant because it is
frequently a component of test batteries.
Intralaboratory and interlaboratory repro-
ducibility is good; however, this test detects
DNAalterations, not mutations.
Evaluationof
HepatoproteefiveAgents
Various antioxidants and scavengers offree
radicals have been tested on in vitro liver
preparations and act as in vivo. During the
last few years, new naturally occurring
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substances of plant origin and from
synthetic compounds have also been
evaluated. These studies have led to the
selection ofthe most active molecules and
have shown that the beneficial effects could
be dependent on the toxin. Moreover,
structure-activity correlations have been
sometimes established and a few molecules
reportedly have their own toxicity
(236,237).
Their effects may depend on the species
studied and the duration oftreatment. (+)-
Cyanidanol-3 was effective on rat hepato-
cytes intoxicated by aflatoxin B, when
added at least 5 min before the mycotoxin,
but was without effect on human hepato-
cytes (236). The significance ofin vivoand
in vitro experimental data to the human
situation may be questioned. Potential anti-
dotes must be added before or just after
toxin administration to be effective. Such
conditions do not usually mimic the human
situation. Repeated administration ofthe
hepatoprotective agent is a more reasonable
approach to obtain improvements inpatients
suffering from chronic liver diseases, as
expected with malotilate. This synthetic
compound, which reportedly protected rats
intoxicatedwith CCts, waswithouteffect on
both rat and human hepatocytes even after
repeated treatment in vitro (238) and on
patients with primary biliary cirrhosis as
shown byamulticenterstudy (239).
Primary hepatocytes of human and
rodent origin have also been used recently
to analyze the mechanism of action of
important classes of chemoprotective
agents that modulate metabolic processing
of carcinogens, such as dithiolethiones,
isothiocyanates, and flavones. By using pri-
mary human hepatocytes, we have shown
that oltipraz, a synthetic derivative of 1,2-
dithione-3-thione, and sulforaphane, an
isothiocyanate found in broccoli, are both
transient inhibitors ofCYPs and inducers
ofGSTs (240,241). However, not all GST
forms are equally induced. Thus oltipraz
mainly induces GST alpha forms that are
not involved in conjugation ofGSH to the
carcinogenic exo-8,9-epoxide metabolite of
aflatoxin B, (240).
In VtoStudies onClaracteristic
IverLesions andAsociated
BiochemicalMecianisms
InducedbyToxicCompounds
Most in vitro investigations on toxic
compounds have been directed to the
reproducibility of liver-specific lesions
and biochemical changes associated with
the lesions.
Characters*icLiverLesions.A number
ofinvestigations have tested in vitro liver
cell models for their ability to reproduce
steatosis and cholestasis and induce specific
organelle injury.
Isolated hepatocytes reproduce in vivo
steatosis. Impairment of fatty acid meta-
bolism and protein synthesis has been
reported in rat hepatocyte suspensions
exposed to drugs known to produce steato-
sis in vivo, e.g., tetracycline (242) and
methotrexate (243).
Isolated hepatocytes in suspension,
hepatocyte couplets, and primary hepato-
cyte cultures have been used to demon-
strate the cholestatic potential ofvarious
compounds that induce cholestasis in vivo
(244). Both morphologic and functional
approaches have been used. The use offlu-
orescent-labeled substrates and imaging
techniques allows visualization ofchanges
in bile canaliculus structures (244,245).
Hepatocyte couplets possess a bile canalicu-
lus that is functional for a few hours.
Phalloidin, bile acids such as taurolitho-
cholate and chenodeoxycholate, erythro-
mycin estolate, and ethylnyl estradiol
inhibited canalicular secretion, whereas non-
cholestatic compounds were ineffective
(246). Compounds that induce cholestasis
byacting on otherlivercell types, e.g., parac-
etamol, galactosamine, and erythromycin
base, as well as chlorpromazine, were also
ineffective (246). The absence ofeffect of
chlorpromazine could be explained by an
incubation period that was too short (2 hr),
as this drug is reportedly cholestatic only
after biotransformation (247). By contrast,
its cholestatic action has been shown in pri-
mary rat hepatocyte cultures after a longer
exposure period (248). Alteration ofactin
filaments by phalloidin treatment has been
observed in both models (244,246).
Tauroursodeoxycholate, which prevents liver
lesions in experimental cholestasis (249),
partly prevented changes in pericanalicular
actin microfilament distribution by tau-
rolithocholate or erythromycin estolate in
isolated rat hepatocyte couplets when added
at equimolar concentrations with either
compound (250).
Specific alterations oforganelles have
been noted with various compounds. Rat
or human hepatocytes exposed to amio-
darone show the formation ofmultilamel-
lar inclusion bodies in the absence ofother
structural changes (251,252). The major
metabolite desethylamiodarone also
induces the formation ofsuch inclusions
(252). Perhexiline maleate and antibiotics
such as erythromycin and trospectin sulfate
(253) are other compounds that induce
accumulation ofconcentric membranes in
lysosomes in cultured hepatocytes. A linear
correlation was obtained between amio-
darone intracellular concentration and the
percent volume density ofinclusion bodies
(252). Myelinoid inclusion bodies were
observed with concentrations only two to
five times as high as the usual drug levels in
amiodarone-treated patients. Peroxisome
proliferation after treatment of rats with
several hypolipidemic agents, including
clofibric acid, nafenopin, and beclofibric
acid, has been reproduced in vitro
(254-256). Specific mitochondrial alter-
ations have been observed in rat hepatocytes
both in vivo and in vitro after treatment
with ditercalinium (257).
BiocbemicalMechanisms. There are
many examples illustrating the use of iso-
lated hepatocytes to determine the mecha-
nisms involved in xenobiotic-mediated
hepatotoxicity. Similar chemical- or drug-
induced biochemical changes in vivo and in
vitro have been demonstrated for various
drugs, particularly the classical hepatotoxins
such as paracetamol, CC14, and halothane,
aswell as for metals.
Hepatotoxicity of paracetamol is
induced by the formation of N-acetyl-p-
benzoquinoneimine (258). When this
reactive metabolite, formed by a CYP-
mediated pathway, is not completely detox-
ified by conjugation with glutathione, it
binds to cellular proteins and induces liver
injury. Species differences in sensitivity to
paracetamol toxic effects have been repro-
duced in isolated hepatocytes. In addition,
by using isolated hamster hepatocytes
Boobis et al. (259) have shown that bind-
ing of the reactive metabolite to cellular
proteins and loss ofcell viability could be
dissociated. After a 90-min incubation with
paracetamol, hamster hepatocytes were
washed to remove all unbound drug and
refreshed with paracetamol-free medium. A
rapid loss ofcell viability was observed and
was prevented by the addition ofN-acetyl-
cysteine. This suggested that the reducing
agent was able to repair oxidative damage
induced by N-acetyl-p-benzoquinoneimine.
The target proteins that interact with parac-
etamol-reactive metabolites have been
analyzed by Bartolome et al. (260). At least
two proteins of 44 and 58 kDa, respec-
tively, were covalently associated with
paracetamol by using antibodies directed
against paracetamol-bound antigens.
CC14 is another hepatotoxicant that has
been studied extensively. A comparative
study in vivoand in primary rat hepatocyte
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cultures led to the conclusion that the
biochemical changes induced by this toxic
compound were generally similar in both
models but more rapid in vitro (261).
Decreased protein and lipoprotein synthe-
sis (262), increased lipid peroxidation
(263), and potentiation of CCl4-induced
liver injury bypretreatment ofthe animals
with 2,5-hexanedione, isopropanol, and
chlordecone (264,265) have been repro-
duced in isolated rat hepatocytes. As in
vivo, the CYP inhibitor SKF-525 inhib-
ited toxicity induced by CC14 (266). In
some studies in vivoobservations were not
reproduced in in vitro models, probably
because of inappropriate experimental
conditions (263). Evidence shows that
CC14 used at relatively high doses induces
membrane injury through a direct solvent
action (267).
The anesthetic halothane causes two
types ofliver damage: transient liver dys-
function in about 20% of anesthetized
patients or, in rare cases, a severe hepatitis
resulting from a cell-mediated immune
response. Both forms are thought to be
related to metabolism of the anesthetic
that occurs through an oxidative and a
reductive pathway.
Several studies have established a
correlation between hepatic centrilobular
injury and low oxygen tension; greater liver
damage has been associated with the for-
mation ofunstable reactive metabolites
through the reductive pathway. Cytotoxicity
in isolated hepatocytes from halothane has
been demonstrated (172,268,269). Rat cells
are more sensitive than their human coun-
terparts (172). In a recent study using
enriched periportal and centrilobular hepa-
tocyte subpopulations in primary culture,
we found that the latterwere the most sensi-
tive to the anesthetic and that increased
reductive metabolism ofhalothane induced
by decreasing oxygen concentration is not a
critical parameter for the occurrence ofliver
damage in these cells (270).
In immune-mediated halothane
hepatitis, neoantigens are generated under
oxidative conditions and involve the for-
mation ofhighly reactive intermediate tri-
fluoroacetyl groups capable ofcovalently
binding to liver proteins (271). Isolated
hepatocytes have also been used to identify
immunogenic moieties that are generated
after exposure to halothane and are respon-
sible for this immune response. An inter-
esting approach has been proposed by
some groups; it involves using hepatocytes
from pretreated animals and analyzing
cytotoxic effects ofsera from patients with
halothane-induced hepatitis. Strong evidence
was provided that in vivo administration of
halothane could generate neoantigenic
determinants on hepatocyte plasma mem-
branes that are very similar, ifnot identical,
to those generated in patients with
halothane hepatitis (272). However, the use
ofanimal hepatocytes could have some limi-
tations. In a recent study (273), we pre-
pared a hapten-specific antifluoroacetyl
antibody that reacted with novel antigens in
primary human hepatocyte cultures exposed
to halothane. These antigens, located in the
endoplasmic reticulum and on the plasma
membrane, had molecular masses similar to
those oftrifluoroacetyl protein antigens
expressed in vivo (273). The cellular distri-
bution ofthese antigenswas compatiblewith
their generation by CYPs and their accessi-
bility to immune effectors in patients. In a
recent study CYP2El was found to be a cell
surface autoantigen in halothane hepatitis
(274). As already noted with clometacin,
another drug known to induce immuno-
allergic hepatitis in humans (275), primary
human hepatocytes could represent a valu-
able model for detecting circulating antibod-
ies in the sera ofpatients with halothane
hepatitis and for characterizing the antigens
recognized bytheseantibodies.
Isolated hepatocytes are also widely
used to study metal-induced toxicity
[reviewed by Klaassen and Stacey (276)].
Some metals such as cadmium and mer-
cury are not essential for life and are con-
sidered only from a toxicologic point of
view, whereas other metals such as iron and
copper are essential and only their excess is
responsible for tissue damage.
Several studies have shown that
cadmium is cytotoxic to isolated hepato-
cytes (276,277) and an approximate com-
parison ofmetal doses in vivo and in vitro
indicates that cell death occurs at similar
levels. Recent studies have shown that
cadmium pretreatment exerts a protective
effect against the genotoxicity of2-acetyl-
aminofluorene in cultured rat hepatocytes
(278). This effect could be related to an
increase ofmetallothionein (thought to be
involved in protection mechanisms) after
cadmium treatment. A protection against
cadmium toxicity in vitrohas been reported
with zinc, lead, and iron (279).
Investigations ofiron toxicity in isolated
hepatocytes after a short period ofexposure
did not demonstrate that this metal was
cytotoxic (280). However, Morel et al.
(281) demonstrated that ferric iron in its
complexed form with nitrilotriacetic acid
induced a dose- and time-dependent
toxicity to primary rat hepatocyte cultures.
The cells were exposed to 5, 20, or 100 jiM
ferric iron up to 48 hr; cytotoxicity was
demonstrated by production offree radicals
and LDH release.
The use ofchelators to remove metals is
an important application ofin vitrohepato-
cyte systems in the assessment of metal
cytotoxicity (282,283). As an example,
pyoverdin Pf, an iron chelator isolated from
pseudomonasfluorescens, was recently found
to prevent cytotoxicity induced by ferric
nitriloacetate in rat hepatocyte cultures. It
appears to be as effective as the well-known
chelator desferrioxamine B (284). Metals
induce toxicity by a variety ofmechanisms.
In addition to peroxidation, which is fre-
quently elicited, inhibition ofmitochon-
drial function or adenosine phosphatases
and interaction with sulfhydryl groups have
been reported (277).
Future Strategies
LiverCellModels
The advantages and limitations ofdifferent
liver preparations are well documented;
the potential use for pharmacotoxicologic
research is summarized in Table 6. Because
the isolated perfused liver model can be used
only for a few hours, two other intact
Table 6. Applications of human in vitroliverpreparations in pharmacotoxicologic studies.
In vitroliverpreparationa
Suspended Cultured
Assay Slices hepatocytes hepatocytes Microsomes
Metabolic profile + ± + ±
Comparative interspecies metabolism + ± + +
Kinetic studies ± + + +
Drug-drug interactions + + + +
Induction studies +b +
Toxicity screening ± +b +
Mechanistic studies + +b +
Unscheduled DNAsynthesis test ± ± +
Abbreviations: ±, possible to some extent; +, currently used; - not suitable. aIsolated organs not included because
of lack ofavailability. bShort-term study.
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systems, i.e., slices (285) and isolated
hepatocytes (286,287), appear to be more
powerful models to mimic the in vivo situa-
tion. Isolated hepatocytes either in suspen-
sion or in culture are used more frequently.
However, one must face the problems of
availability and instability in primary culture
ofnormal hepatocytes and the inability of
permanent hepatocyte cell lines to express all
ofthe functions exhibited by their normal
counterparts in vivo.
Normal Hepatocytes. The major
limitation in the use ofnormal hepatocytes
is the availability ofhuman samples and, to
a lesser degree, of large mammal livers.
Technical, safety, and ethical problems are
associated with the use ofhuman liver tis-
sue. The opportunity to obtain hepatocytes
from some animal species such as monkey
or dog is also limited, primarily for ethical
and economical reasons. Because of the
progress in liver transplantation in humans,
nonpathologic whole organs available for
cell isolation are now extremely scarce.
Pathologic and injured livers can be used;
however, cell yields depend on the extent
ofthe lesions, e.g., steatosis. Cirrhotic liv-
ers are poorly dissociated by collagenase
treatment. Consequently, human hepato-
cytes are now more frequently prepared
from surgical tissuepieces; this requires care-
ful evaluation oftheir functional activities
before anydata can becorrectlyinterpreted.
Human liver samples must be treated as
biohazardous. Ideally, possible infection of
the donor by hepatitis and/or human
immunodeficiency viruses should be deter-
mined before handling and transport of
liver tissue.
The scarcity and unpredictability of
human liver tissue lead to the question of
whether liver tissue and liver cell banks
should be established and made available to
those willing to conduct investigations with
human liver. Although cell recovery is still
limited, there is now evidence that both
human and animal liver parenchymal cells
can be cryopreserved for months or even
years. However, it is not conceivable that
supplies ofhuman liver tissue will dramati-
cally increase in the future ifone abides by
ethical and legal aspects, and consequently
no large tissue or cell bank that will allow
distribution ofsamples through a large area
could be established. One way to accom-
modate both ethical aspects and the need
for functionally characterized samples
might be to set up a database and a tissue
bank under the control ofan institutional
organization at the national level, with cells
or tissues distributed as reference samples.
Another critical problem is the
functional stability ofnormal adult hepato-
cytes in primary culture. Recent investiga-
tions have clearly established that three
groups offactors, i.e., soluble factors, extra-
cellular matrix components, and cell-cell
interactions, improve in vitro maintenance
ofliver-specific functions. However, what-
ever the culture conditions used, hepato-
cytes exhibit phenotypic changes within a
few days in vitro. The coculture model
that associates hepatocytes with rat liver
epithelial cells remains the most powerful
in vitro system (288). Knowledge offactors
required for hepatocyte replication in vitrois
another important challenge for the future.
Therefore, significant progress must be
made to improve experimental conditions-
progress that will lead to prolonged mainte-
nance ofliver-specific functions and/or to
more than a few cycles ofreplication in
vitro. Such improvements would be particu-
larly advantageous for long-term hepatic
toxicologyand carcinogenesis studies.
Hepatocyte Cell Lines. The develop-
ment ofimmortalized hepatocyte cell lines
represents a promising alternative to non-
proliferating or poorly replicating normal
hepatocytes. Development of immortal-
ized animal hepatocyte lines that retain
various specific liver properties is proving
difficult. Immortalized human hepato-
cytes would be the optimal choice, but
they appear to be still more difficult to
obtain and maintain in culture with some
liver-specific functions (289). This means
that optimal conditions for immortalizing
and culturing adult hepatocytes must be
further defined.
An interesting new approach is to
establish hepatocyte lines from transgenic
mice. Immortalized nontransformed fetal
hepatocyte lines obtained bydissociation of
the liver before visible pathologic changes
reportedly retain highly differentiated
functions for many months when cultured
in a sophisticated medium (290).
Presently, attempts are being made
to transfect human hepatocyte cell lines
with cDNA encoding CYPs in which
expression is missing and to obtain trans-
genic mice expressing human drug-
metabolizing enzymes.
In VWn)ToxicityTests
Considerable information has been
published regarding the use ofthe isolated
hepatocyte, either in suspension or in pri-
mary culture, for in vitro toxicity testing
(286,287). Although carried out with dif-
ferent methodologies, these studies give us
agood idea aboutadvantages and limitations
ofthe model for screening and mechanistic
analysis ofpotentially toxiccompounds.
The interlaboratory validation schemes
previously conducted using dassical experi-
mental conditions and various in vitro end
points indicate that no single protocol (i.e.,
one culture condition) can be used for test-
ing every compound (174) and that prob-
lems of interpretation can be greatly
magnified when tests involving different
mechanisms oftoxicity and end points are
compared (291).
Early phenotypic changes occurring in
hepatocytes after seeding are a major limi-
tation for long-term toxicity screening.
However, the use of more sophisticated
culture conditions (e.g., cocultures) could
overcome this drawback.
Consequently, the following strategy is
proposed for short-term and long-term
toxicity studies. Compounds could first be
tested on nonhepatic cells (e.g., fibroblasts,
cell lines) using nonspecific end points over
a short period not exceeding 20 to 24 hr,
and IC50 values would be calculated. This
study would elicit information on com-
pound properties such as solubility and
intrinsic toxicity. These data would be use-
ful for testing the compound on primary
rat hepatocytes in a second step. When
liver-specific chemical-induced cellular
lesions are suspected, appropriate liver-spe-
cific indicators would be used. Long-term
cytotoxicity would be estimated using
sophisticated culture systems e.g., cocul-
tures. The cultures would be exposed daily
for either a few days or 1 to 2 weeks. If
liver-specific toxicity is demonstrated with
animal hepatocytes, and particularly if
species differences exist in metabolic path-
ways of the test compound, the use of
human hepatocytes would be desirable.
Another step could be carried out in vitro
using mixed cultures ofhepatocytes and
nonhepatic target cells (e.g., kidney cells).
This last model system would determine
whether metabolites formed by liver cells
would be toxic for other cells. These
cultures could be performed in static con-
ditions (or preferably in perifusion condi-
tions), thereby better mimicking in vivo
xenobiotic clearance (292).
In addition to intact hepatocyte
models, liver S9, microsomes, and genetic-
ally engineered cells are also of interest,
particularly for the studyofmutagens. One
may wonder whether the rat liver S9 could
be replaced by microsomes from genetic-
ally engineered cells expressing human
CYPs in appropriate concentrations in the
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Ames test. It could also be possible to
mimic the human situation, including the
genetic defects in some CYPs.
Conclusions
Over the last few decades, major progress
has been made in the development of
reproducible methods for the preparation
and culture ofdifferentiated hepatocytes
and liver slices ofboth animal and human
origin. The usefulness ofisolated hepato-
cytes for drug metabolism and toxicity
studies has been demonstrated. It is time to
standardize methodologies that could be
validated and accepted by the scientific
community and by regulatory agencies.
However, it should be considered that if a
great deal ofinformation can be obtained
from in vitro models, the appropriate strat-
egy in the course ofdrug development is
their use in alternance with in vivo
studies. Moreover, some limitations exist
related to the occurrence ofearly pheno-
typic changes in cultured hepatocytes, their
low proliferating capacity, and the scarce
availability of human hepatocytes. The
major challenges ofthe coming years will be
to further improve culture conditions for
primary adult hepatocytes and to obtain
immortalized, untransformed hepatocytes
retaining liver-specific functions. The use of
new technologies (e.g., scanning laser
cytometer, confocal microscopy) should
also allow the development ofnew, reliable,
and sensitive toxicity tests.
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